Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Standard Dose
3.75%;EQ 1.2% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 209610 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE Form and strength GEL;TOPICAL - 3.75%;EQ 1.2% BASE Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2024-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 209610 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE Form and strength GEL;TOPICAL - 3.75%;EQ 1.2% BASE Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2024-08-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE) | Drug Monograph | MedicHelpline